Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis

被引:143
作者
Nehra, V
Angulo, P
Buchman, AL
Lindor, KD
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Northwestern Univ, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA
关键词
steatohepatitis; choline; free fatty acids; celiac sprue; obesity;
D O I
10.1023/A:1012338828418
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of this study was to determine if a relationship exists between nonalcoholic steatohepatitis (NASH) and serum levels of free fatty acids, choline deficiency, or celiac disease. Forty-seven patients with liver biopsy proven NASH were enrolled. Total serum free fatty acids and anti-endomysial antibodies were determined in all patients, while plasma free and phospholipid-bound choline were determined in 29 patients. Total serum free fatty acid concentration correlated significantly with female gender and serum albumin concentration. Patients with severe fibrosis on liver biopsy had significantly greater serum concentration of free fatty acids than patients without severe fibrosis. Plasma free and phospholipid-bound choline levels were normal and. no significant correlation was found between the concentration of plasma free or phospholipid bound choline, and the severity of liver damage. Only one of the 47 patients with NASH had a positive titer for the anti-endomysial antibody. In conclusion, increased serum concentrations of free fatty acids were found in NASH and were associated with development of more severe liver disease. Neither choline deficiency nor celiac sprue by anti-endomysial antibody testing was associated with NASH.
引用
收藏
页码:2347 / 2352
页数:6
相关论文
共 47 条
[1]   INJURY PRODUCED BY FREE FATTY-ACIDS TO LYSOSOMES AND MITOCHONDRIA IN CULTURED HEART-MUSCLE AND ENDOTHELIAL CELLS [J].
ACOSTA, D ;
WENZEL, DG .
ATHEROSCLEROSIS, 1974, 20 (03) :417-426
[2]   FATTY LIVER HEPATITIS AND CIRRHOSIS IN OBESE PATIENTS [J].
ADLER, M ;
SCHAFFNER, F .
AMERICAN JOURNAL OF MEDICINE, 1979, 67 (05) :811-816
[3]  
ALPERS DH, 1993, DISEASES LIVER, V2, P825
[4]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[5]  
Angulo P, 1999, CLIN G MED MANAG, P367
[6]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[7]  
BARDELLA MT, 1995, HEPATOLOGY, V22, P833, DOI 10.1002/hep.1840220322
[8]  
BEDOSSA P, 1994, HEPATOLOGY, V19, P1262, DOI 10.1016/0270-9139(94)90876-1
[9]   Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes [J].
Berson, A ;
De Beco, V ;
Lettéron, P ;
Robin, MA ;
Moreau, C ;
El Kahwaji, J ;
Verthier, N ;
Feldmann, G ;
Fromenty, B ;
Pessayre, D .
GASTROENTEROLOGY, 1998, 114 (04) :764-774
[10]  
BODARDUS C, 1984, J CLIN INVEST, V74, P1238